Vatican City–(Newsfile Corp. – May 20, 2024) – The Pontifical Academy of Sciences is proud to announce that Dr. Christina Rahm will be honored at its prestigious summit on May 29, 2024, at the Vatican. A distinguished scientist, entrepreneur, and philanthropist, Dr. Rahm has been recognized for her significant contributions to healthcare innovation and her unwavering commitment to improving global health.
Dr. Rahm will take the stage to share her insights and groundbreaking work in health science, focusing on her innovative approaches to nutraceuticals and wellness. Her speech is eagerly anticipated as a highlight of the summit, which gathers distinguished scientists, policymakers, and leaders from around the world to discuss solutions to some of humanity’s most pressing challenges.
The Pontifical Academy of Sciences Summit serves as a platform for dialogue and collaboration among the world’s leading minds, aiming to foster scientific advancements and ethical solutions for the betterment of society. Dr. Rahm’s participation underscores her role as a vanguard in the intersection of science, health, and ethics, aligning perfectly with the Academy’s mission to bridge faith and reason in the pursuit of knowledge and service to humanity.
We invite members of the press and the public to join us in celebrating Dr. Rahm’s achievements and contributions at this significant event. Her presence at the Vatican is not only an honor but a testament to the global impact of her work.
For more information about the summit and Dr. Rahm’s involvement, please visit the Pontifical Academy of Sciences‘ official website.
About Dr. Christina Rahm
Dr. Rahm is a globally recognized scientist, entrepreneur, and founder of the Rahm Foundation, dedicated to providing innovative health solutions worldwide. Her work spans various disciplines, focusing on the development of nutraceuticals and wellness programs aimed at enhancing physical and mental health. With her extensive background in nanotechnology, bioscience, engineered medical science, and commitment to providing healthy solutions, Dr. Rahm has ensured her products* are a testament to her philosophy of helping globally, leading boldly, and living harmoniously. The most important environment is YOURS! #therahmeffect
About the Pontifical Academy of Sciences
Established in 1603, the Pontifical Academy of Sciences is a scientific academy of Vatican City committed to promoting the progress of the mathematical, physical, and natural sciences and the study of related epistemological problems.
*We do not claim or imply our products prevent, treat, or cure any illness, disorder, or disease. We focus on the ROOT cause to support your pathway to create Greatness.
Medical Disclaimer-The information provided is for educational purposes only. It is not intended as medical advice or a substitute for the medical advice of a physician or other qualified health care professionals. This information is not to be used for self-diagnosis. Always consult your doctor for medical advice or information about diagnosis and treatment. Statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease. ROOT is a company founded on improving people’s understanding of how toxins and chemicals can harm your health. Instead of focusing on symptoms, ROOT targets the underlying root cause with natural wellness.
Contact:
Madison Baber
madison@rprfirm.com
2102132426
Photos: https://drive.google.com/drive/folders/15Veoy7MLeOgUSLz0n2CD7s6qSZU2E2hD?usp=drive_link
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/209879
NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…
DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…
Diarrhea is one of the most common reasons for veterinary visits for dogs and the…
Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers…
FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…